Publications by authors named "Y A Vyalkina"
Article Synopsis
- The study aimed to assess how a decrease in glomerular filtration rate (GFR) impacts the prognosis of patients with chronic heart failure (CHF) and to evaluate the real-world prescribing practices for CHF treatment based on GFR levels in the Tyumen region.
- In a review of 4,077 CHF patients from January 2020 to May 2023, it was found that 34.6% had a GFR of less than 60 ml/min/1.73 m², with women being more affected. The risk of mortality was higher for patients with significantly lower GFR values.
- The analysis indicated a decline in the prescription rates of ACE inhibitors, beta-blockers, and mineral
Article Synopsis
- This study investigated how giving an 80 mg loading dose of atorvastatin before coronary angiography affects the risk of contrast-induced nephropathy (CIN) in patients with STEMI.
- In the analysis of 386 STEMI patients, those who received atorvastatin had a significantly lower incidence of CIN (10.5%) compared to those who did not (24.4%).
- The results also showed that serum creatinine levels returned to baseline values more frequently in the atorvastatin group (66.3% vs. 50.6%) by day 7, indicating better kidney recovery.
Background: Despite the PCI in patients with ST-segment elevation myocardial infarction (STEMI) the development of acute heart failure (AHF) Killip ≥II is associated with a poor prognosis.
Aim: To identify predictors of the development of AHF and the prognostic value of AHF in patients with STEMI after PCI.
Materials And Methods: In a prospective study, which lasted 6 months, included 233 patients (average age of 62.
Aim: To assess frequency and prognostic value of contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI).
Materials And Methods: We included in this prospective observational study 233 patients with STEMI. Duration of follow-up was 6 months.